TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 4028805

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 25
Study: 31284568

Group type: EXPERIMENTAL
Intervention: Exercise program plus food education program (experimental group; n = 20)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Exercise program (control group; n = 16)
Number of subjects: 36
Study: 30056355

Group type: EXPERIMENTAL
Intervention: Intramyometrial vasopressin plus rectal misoprostol (30 min before procedure)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intramyometrial vasopressin alone
Number of subjects: 60
Study: 27806250

Group type: EXPERIMENTAL
Intervention: Cannabis cigarette (4% THC)
Number of subjects: 18
Study: 24700631

Group type: EXPERIMENTAL
Intervention: Strength training group (19 boys, 22 girls) training twice a week for 8 weeks
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Endurance training group (21 boys, 24 girls) training twice a week for 8 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (18 boys, 21 girls; no training program)
Number of subjects: 125
Study: 22064608

Group type: EXPERIMENTAL
Intervention: 9-month training program
Number of subjects: 84

Group type: COMPARATOR
Intervention: 3-month training program
Number of subjects: 84
Study: 20409203

Group type: EXPERIMENTAL
Intervention: 3Mix
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitapex
Number of subjects: 50
Study: 18828243

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) systems as a supplement to standard self-monitoring of blood glucose (SMBG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard self-monitoring of blood glucose (SMBG) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) systems
Number of subjects: 0
Study: 16202722

Group type: EXPERIMENTAL
Intervention: Cervical biopsies taken at different quadrants (12 o'clock, 6 o'clock, 3 o'clock, 9 o'clock)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervigrams demonstrating visible intraepithelial lesions and acetowhitening
Number of subjects: 0
Study: 12683344

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 41

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 41
Study: 10078888

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 62

Group type: COMPARATOR
Intervention: T'ai Chi
Number of subjects: 62
Study: 7668039

Group type: EXPERIMENTAL
Intervention: WC/rBS cholera vaccine
Number of subjects: 541

Group type: COMPARATOR
Intervention: Escherichia coli K12 placebo
Number of subjects: 541
Study: 8267992

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium chloride (50 mmol)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 130
Study: 4055163

Group type: EXPERIMENTAL
Intervention: Paracetamol + l‐methionine (5:1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Paracetamol (1,500 mg)
Number of subjects: 10
Study: 31376419

Group type: EXPERIMENTAL
Intervention: CRISPR/dCas9 system to label genomic loci
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-resolution wide-field imaging
Number of subjects: 0
Study: 29549417

Group type: EXPERIMENTAL
Intervention: Screening group (individuals who attended screening)
Number of subjects: 139075

Group type: EXPERIMENTAL
Intervention: Screening group (individuals diagnosed with diabetes)
Number of subjects: 139075

Group type: COMPARATOR
Intervention: No-screening group (unscreened individuals diagnosed with diabetes)
Number of subjects: 139075
Study: 27513414

Group type: EXPERIMENTAL
Intervention: Back school program applied over 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Booklet for home use (Control)
Number of subjects: 40
Study: 24655552

Group type: EXPERIMENTAL
Intervention: Oral HRT (1mg 17β‐estradiol and 0.5mg norethisterone acetate for 6 months)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Transdermal HRT (50μg/day estradiol alone for days 1-14 and 50μg/day estradiol plus 0.25mg/day norethisterone acetate for days 15-28 for 6 months)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Oral HRT
Number of subjects: 76

Group type: COMPARATOR
Intervention: Transdermal HRT
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both oral and transdermal HRT
Number of subjects: 76
Study: 22295815

Group type: EXPERIMENTAL
Intervention: ST 9 plus SGB group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ST 9 group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Common acupuncture group
Number of subjects: 120
Study: 19657689

Group type: EXPERIMENTAL
Intervention: 6-month subcutaneous denosumab injection (60 mg) plus weekly oral placebo
Number of subjects: 1693

Group type: COMPARATOR
Intervention: Weekly alendronate tablet (70 mg) plus 6-month subcutaneous placebo injection
Number of subjects: 1693
Study: 18696021

Group type: EXPERIMENTAL
Intervention: s1 (initial slope of the VCO2/VO2-curve)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: peak VO2
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: NT-proBNP serum-levels
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: NYHA-class
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: LVEF
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: combined endpoint of cardiovascular death and rehospitalization due to HF
Number of subjects: 103
Study: 16195026

Group type: EXPERIMENTAL
Intervention: Pose method of running (12 weeks of instruction)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual running technique (control group)
Number of subjects: 16
Study: 11812401

Group type: EXPERIMENTAL
Intervention: Stenting
Number of subjects: 100

Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 100
Study: 10518294

Group type: EXPERIMENTAL
Intervention: Re‐Flex Vertical Shock Pylon (VSP) prosthesis
Number of subjects: 5

Group type: COMPARATOR
Intervention: Flex‐Foot (FF) prosthesis
Number of subjects: 5

Group type: COMPARATOR
Intervention: Solid Ankle Cushion Heel (SACH) foot
Number of subjects: 5
Study: 7547154

Group type: EXPERIMENTAL
Intervention: Intensive medication counselling for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: No counselling
Number of subjects: 0
Study: 2343272

Group type: EXPERIMENTAL
Intervention: Fluoride varnish applications every 3 months
Number of subjects: 254

Group type: COMPARATOR
Intervention: Fluoride varnish applications every 6 months
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Fluoride varnish applications every 3 months (high baseline DMFS)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Fluoride varnish applications every 6 months (high baseline DMFS)
Number of subjects: 254
Study: 35296

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Timolol (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31806533

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (VR)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Video
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Electronic pamphlet (e-pamphlet)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Vaccine Information Statements (VIS) only
Number of subjects: 171
Study: 31207115

Group type: EXPERIMENTAL
Intervention: Hyaluronidase‐1 (HYAL‐1) expression measured by RT‐PCR in tumour tissues
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Saliva HA levels measured by ELISA method
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tumour tissue HA levels
Number of subjects: 50
Study: 28163006

Group type: EXPERIMENTAL
Intervention: Availability of healthier products and promotional signs on snack vending machines
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Healthier product guidelines on beverage machines
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Price reductions for healthier items
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Three-way interaction of availability, price reduction, and promotional signs
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Overall shift to healthier purchasing
Number of subjects: 56
Study: 25854020

Group type: EXPERIMENTAL
Intervention: Integrated therapy of acupuncture and pingganjianpi decoction
Number of subjects: 47

Group type: COMPARATOR
Intervention: Haloperidol tablets (0.05 mg/kg per day, twice a day for 30 days)
Number of subjects: 47
Study: 23986021

Group type: EXPERIMENTAL
Intervention: Vertical incision technique
Number of subjects: 163

Group type: COMPARATOR
Intervention: Horizontal incision technique
Number of subjects: 163
Study: 21371167

Group type: COMPARATOR
Intervention: Intrathecal 0.5% bupivacaine 0.2-0.4 mg·kg(‐1) and intravenous 2 ml saline (Group B)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Intrathecal 0.5% bupivacaine 0.2-0.4 mg·kg(‐1) plus 1 μg·kg(‐1) clonidine and intravenous 2 ml saline (Group BCit)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 0.2-0.4 mg·kg(‐1) and intravenous 1 μg·kg(‐1) clonidine in 2 ml of saline (Group BCiv)
Number of subjects: 59
Study: 18855032

Group type: EXPERIMENTAL
Intervention: Combined (1)H and (31)P MR spectroscopic imaging (MRSI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 14
Study: 17619660

Group type: EXPERIMENTAL
Intervention: Interactive digital images of drug products and online quizzes
Number of subjects: 0
Study: 15049877

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11673035

Group type: EXPERIMENTAL
Intervention: Gemifloxacin 320 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Trovafloxacin 200 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Gemifloxacin
Number of subjects: 12
Study: 9626153

Group type: EXPERIMENTAL
Intervention: 0.6 IU/day recombinant human growth hormone (rhGH)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 1.2 IU/day recombinant human growth hormone (rhGH)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 1.8 IU/day recombinant human growth hormone (rhGH)
Number of subjects: 47
Study: 7897380

Group type: EXPERIMENTAL
Intervention: Combined hepatitis A (720 ELISA units) and hepatitis B (20 micrograms) vaccine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Mixed administration of hepatitis A and hepatitis B vaccines
Number of subjects: 150

Group type: COMPARATOR
Intervention: Separate administration of hepatitis A and hepatitis B vaccines
Number of subjects: 150
Study: 3429061

Group type: EXPERIMENTAL
Intervention: imidazole salicylate (750 mg t.i.d.)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: indomethacin (50 mg b.i.d. plus placebo)
Number of subjects: 9
Study: 30317290

Group type: EXPERIMENTAL
Intervention: 1gm acetaminophen
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 220
Study: 28962596

Group type: EXPERIMENTAL
Intervention: Chiropractic treatment individualized to each woman
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional primary health care (Control)
Number of subjects: 56
Study: 26314215

Group type: EXPERIMENTAL
Intervention: Listening to recorded children's songs with integrated heartbeat sounds (Baby Go To Sleep compact disc) before and during the head CT (Exp group, n=30)
Number of subjects: 62

Group type: COMPARATOR
Intervention: No music (Con group, n=32)
Number of subjects: 62
Study: 23216412

Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg b.d.
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Loxoprofen 60 mg t.d.s.
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 20864893

Group type: EXPERIMENTAL
Intervention: 0.3 mg flumazenil
Number of subjects: 24
Study: 18710436

Group type: EXPERIMENTAL
Intervention: Wheat-based starch hydrolysates, glucose syrups, maltodextrins
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 17131980

Group type: EXPERIMENTAL
Intervention: 10 weeks of prayer/distant healing from professional healers
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 10 weeks of prayer/distant healing from nurses with no prior training or experience in distant healing
Number of subjects: 156

Group type: COMPARATOR
Intervention: No distant healing (control group)
Number of subjects: 156
Study: 14762500

Group type: EXPERIMENTAL
Intervention: 0.5% chlorhexidine gel (CHX), n = 15
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo gel, n = 15
Number of subjects: 30
Study: 11424245

Group type: EXPERIMENTAL
Intervention: Advantage‐S (spermicide containing nonoxynol‐9)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vaginal lubricant (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low dose N‐9 products
Number of subjects: 100
Study: 8796770

Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 1618247

Group type: EXPERIMENTAL
Intervention: 0.25% prednicarbate cream
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.1% betamethasone-17-valerate cream
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.05% clobetasol-17-propionate cream
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 24
Study: 6377071

Group type: EXPERIMENTAL
Intervention: Early PEEP at 8 cm H2O
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (no PEEP)
Number of subjects: 92
Study: 30426921

Group type: EXPERIMENTAL
Intervention: Indoor residual spraying (IRS)
Number of subjects: 7211

Group type: EXPERIMENTAL
Intervention: Insecticide impregnation of bednets
Number of subjects: 7211

Group type: EXPERIMENTAL
Intervention: Insecticide wall painting
Number of subjects: 7211

Group type: EXPERIMENTAL
Intervention: Fever camps
Number of subjects: 7211

Group type: EXPERIMENTAL
Intervention: Female community health volunteers (FCHVs)
Number of subjects: 7211

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 7211
Study: 28730841

Group type: EXPERIMENTAL
Intervention: Individual coaching sessions, tailored information, and materials for 6 months
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 314
Study: 26519669

Group type: EXPERIMENTAL
Intervention: 3 DAAs (setrobuvir, danoprevir/r, mericitabine) plus ribavirin for 12 weeks (Group A: G1a)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 3 DAAs (setrobuvir, danoprevir/r, mericitabine) plus ribavirin for 24 weeks (Group B: G1a)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 2 DAAs (setrobuvir, danoprevir/r) plus ribavirin for 12 weeks (Group E: G1b)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 2 DAAs (setrobuvir, danoprevir/r) plus ribavirin for 24 weeks (Group D: G1b)
Number of subjects: 110
Study: 24555499

Group type: EXPERIMENTAL
Intervention: Intraurethral 2% lidocaine jelly instilled for 15 minutes (Group C)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Intraurethral 2% lidocaine jelly instilled for 5 minutes (Group A)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Intraurethral 2% lidocaine jelly instilled for 20 minutes (Group D)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Intraurethral 2% lidocaine jelly instilled for 10 minutes (Group B)
Number of subjects: 400
Study: 22853822

Group type: EXPERIMENTAL
Intervention: Hypoxia group (HG)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 26
Study: 19272659

Group type: EXPERIMENTAL
Intervention: Incremental acetylcholine (Ach; 20, 50 and 100 microg/min) infusion
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (103 matched subjects, 64 males, average age 51.3 years) with angiographically normal LAD and BDI <10, HAM-D17 <7
Number of subjects: 52
Study: 17008536

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) after inductions 1 and 2
Number of subjects: 317

Group type: COMPARATOR
Intervention: Control group (no G-CSF)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Both groups (G-CSF and control)
Number of subjects: 317
Study: 15978638

Group type: EXPERIMENTAL
Intervention: Regular low to moderate intensity physical exercise
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study: 11923797

Group type: EXPERIMENTAL
Intervention: DUETT vascular hemostasis device
Number of subjects: 630

Group type: COMPARATOR
Intervention: Standard manual compression
Number of subjects: 630
Study: 10457868

Group type: EXPERIMENTAL
Intervention: 20 micrograms ethinyl estradiol (EE) + 75 micrograms gestodene (GSD) (Harmonet, Wyeth‐Lederle; n = 15)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 20 micrograms EE + 150 micrograms desogestrel (DSG) (Mercilon, Organon n = 17)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 30 micrograms EE + 150 micrograms DSG (Marvelon, Organon, n = 12)
Number of subjects: 44
Study: 7501709

Group type: EXPERIMENTAL
Intervention: D2 electrode placement
Number of subjects: 10

Group type: COMPARATOR
Intervention: L2 electrode placement
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Subjective assessment
Number of subjects: 10
Study: 1886348

Group type: EXPERIMENTAL
Intervention: Betaxolol 0.5%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 0
Study: 31626010

Group type: EXPERIMENTAL
Intervention: Posterior tilt ≥20°
Number of subjects: 555

Group type: COMPARATOR
Intervention: Posterior tilt <20°
Number of subjects: 555
Study: 29303810

Group type: EXPERIMENTAL
Intervention: TEP hernia repair with lightweight (Ultrapro) mesh
Number of subjects: 950

Group type: COMPARATOR
Intervention: TEP hernia repair with heavyweight (Prolene) mesh
Number of subjects: 950
Study: 26419871

Group type: EXPERIMENTAL
Intervention: SSGs in combination with cultured autologous epidermal cells (ECs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment with SSGs
Number of subjects: 40
Study: 24626433

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg) plus Ezetimibe (10 mg) daily
Number of subjects: 2353

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2353

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 2353

Group type: COMPARATOR
Intervention: Placebo (AURORA trial)
Number of subjects: 2353

Group type: EXPERIMENTAL
Intervention: Any LDL-C-lowering therapy
Number of subjects: 2353
Study: 22298168

Group type: EXPERIMENTAL
Intervention: Electrical cardioversion in Euthyroid patients (Group 1)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Electrical cardioversion in Hyperthyroid patients (Group 2)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Clinical hyperthyroid patients
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Subclinical hyperthyroid patients
Number of subjects: 67

Group type: COMPARATOR
Intervention: Comparison of clinical and subclinical hyperthyroid patients to Euthyroid patients
Number of subjects: 67
Study: 19761983

Group type: EXPERIMENTAL
Intervention: FDG PET imaging with revascularization
Number of subjects: 182

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Revascularization
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Creatinine increase (for a 10-mumol/l increase)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: LVEF decrease (for a 2% decrease)
Number of subjects: 182
Study: 17209666

Group type: EXPERIMENTAL
Intervention: Lercanidipine/enalapril 10mg/10mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lercanidipine/enalapril 10mg/20mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lercanidipine/enalapril
Number of subjects: 0
Study: 15126816

Group type: EXPERIMENTAL
Intervention: Transurethral needle ablation (TUNA)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 121
Study: 11458142

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (lower expectations)
Number of subjects: 135
Study: 9721113

Group type: EXPERIMENTAL
Intervention: Structured health visitor management with dietetic, paediatric, and social work input
Number of subjects: 229

Group type: COMPARATOR
Intervention: Conventional management (Control)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Structured health visitor management
Number of subjects: 229
Study: 7987431

Group type: EXPERIMENTAL
Intervention: Vocal hygiene education program for 2 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group of teachers
Number of subjects: 12
Study: 2563955

Group type: EXPERIMENTAL
Intervention: Bevantolol
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 1106848

Group type: EXPERIMENTAL
Intervention: Dibromodulcitol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 0
Study: 31883044

Group type: EXPERIMENTAL
Intervention: Cross-linked hyaluronan (cHA) gel applied at the end of hysteroscopy and 5-7 days after operation
Number of subjects: 306

Group type: COMPARATOR
Intervention: Standard hysteroscopy
Number of subjects: 306
Study: 31172172

Group type: EXPERIMENTAL
Intervention: Whole eggs (100 g, ∼2 whole eggs per day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Yolk-free eggs (100 g, ∼2 yolk-free eggs per day)
Number of subjects: 20
Study: 28063841

Group type: EXPERIMENTAL
Intervention: External physical vibration lithecbole
Number of subjects: 173

Group type: COMPARATOR
Intervention: Retrograde intrarenal surgery
Number of subjects: 173
Study: 26043564

Group type: EXPERIMENTAL
Intervention: Acupressure at positive points (liniao point and Qihai (RN6) combined with Guanyuan (RN4), Zhongji (RN3), Shenshu (BL23), Zusanli (ST36), Sanyinjiao (SP6), Taixi (K13))
Number of subjects: 107

Group type: COMPARATOR
Intervention: Negative acupressure at sham-acupoints
Number of subjects: 107

Group type: COMPARATOR
Intervention: Conventional sitz bath
Number of subjects: 107
Study: 23757297

Group type: EXPERIMENTAL
Intervention: Tibial neurotomy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Botulinum toxin (BTX)
Number of subjects: 16
Study: 22086091

Group type: EXPERIMENTAL
Intervention: Transforaminal (TF) epidural steroids
Number of subjects: 42

Group type: COMPARATOR
Intervention: Interlaminar (IL) epidural steroids
Number of subjects: 42
Study: 18435479

Group type: EXPERIMENTAL
Intervention: Menthol inhalation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (eucalyptus oil)
Number of subjects: 42